öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º°×È»
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º169

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿ÆѧÄÚ·ÖÃÚÓë´úл²¡
Ñо¿ÁìÓò£º ÌÇÄò²¡¼°Æä²¢·¢Ö¢µÄ»ù´¡ÓëÁÙ´²£¬°üÀ¨ÌÇÄò²¡µÄÓÅ»¯ÖÎÁÆ¡¢ÌÇÄò²¡Î¢Ñª¹Ü²¢·¢Ö¢µÄ»ù´¡ÓëÁÙ´²Ñо¿ºÍÌÇ... [Õ¹¿ª]


Ñо¿ÁìÓò£º ÌÇÄò²¡¼°Æä²¢·¢Ö¢µÄ»ù´¡ÓëÁÙ´²£¬°üÀ¨ÌÇÄò²¡µÄÓÅ»¯ÖÎÁÆ¡¢ÌÇÄò²¡Î¢Ñª¹Ü²¢·¢Ö¢µÄ»ù´¡ÓëÁÙ´²Ñо¿ºÍÌÇÄò²¡»ùÒòÕï¶ÏºÍÖÎÁÆÑо¿¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**-7137
µç×ÓÓʼþ£ºbairan5556@163.com


¸öÈ˼òÊö :
°×È»£¬Å®£¬51Ë꣬²©Ê¿Ñ§Î»£¬ÏÖÈδóÁ¬Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½ÔºÄÚ·ÖÃÚ¿ÆÈý²¿Ö÷ÈΣ¬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£ÈÎÁÉÄþʡҽʦЭ»áÄÚ¿Æ·Ö»áίԱ£¬ÖлªÒ½Ñ§»á´óÁ¬ÊÐÄÚ·ÖÃÚѧ»áίԱ¡£Å©¹¤µ³Ô±¡£´ÓÒ½28Ä꣬´ÓÊÂÄÚ·ÖÃÚ¼°´úл²¡¹¤×÷23Ä꣬ÁÙ´²¾­Ñé·á¸»£¬¶ÔÓÚÄÚ·ÖÃÚ³£¼û²¡¡¢¶à·¢²¡¡¢Î£ÖØÖ¢ÇÀ¾È¾ùÓÐ×ŷḻµÄÁÙ´²¾­Ñ飬ָµ¼¸±Ö÷ÈÎҽʦ¡¢Ö÷ÖÎҽʦ¿ªÕ¹ÁÙ´²¹¤×÷£¬²¢³Ðµ£Á˸÷¸ö²ã´ÎµÄ½Ìѧ¹¤×÷¡£

¿ÆÑй¤×÷ :
Ö÷³Ö¼°²ÎÓë¿ÎÌ⣺Ö÷³Ö£º¡¶ÌÇÄò²¡Éö²¡ÉöС¹ÜÉÏƤϸ°û±íÐÍת»¯ÖÐmiRNAµÄµ÷¿Ø»úÖÆÓë¸ÉÔ¤¡·£¬ÁÉÄþÊ¡¿Æ¼¼Ìü×ÔÈ»»ù½ðÏîÄ¿£¬ºÏͬ±àºÅ£º**-401,2013Äê01Ô ÖÁ 2015Äê12Ô£¬2016Äê½áÌ⣬¾­·Ñ5Íò£¬ÅÅÃûµÚÒ»£»
²ÎÓ룺£¨1£©¡¶1ÐÍÌÇÄò²¡»ùÒòÖÎÁÆʵÑéÑо¿¡·£¬ÁÉÄþÊ¡½ÌίÁ¢Ïî¹¥¹Ø¼Æ»®¿ÎÌ⣬ÏîÄ¿±àºÅ**£¬1997ÄêÁ¢Ï2002Äê½áÌ⣬¾­·Ñ10Íò ÅÅÃûµÚ¶þ£» £¨2£©ºÏ×÷¿ÎÌ⡶2ÐÍÌÇÄò²¡¼°Æä²¢·¢Ö¢Ô¤¾¯¡¢¸ÉÔ¤µÄÑо¿¡·£¬ ¹ú¼Ò¿Æ¼¼²¿Ê®Îå¿Æ¼¼¹¥¹Ø¿ÎÌâ2001ÄêÁ¢ÏÏîÄ¿±àºÅ2001BA702B01,2006Äê³É¹¦¹ö¶¯ÎªÊ®Ò»Îå¿Æ¼¼Ö§³Å¿ÎÌ⣬¹²14¸öÖÐÐÄ£¬±¾ÈËΪ±¾ÖÐÐĵڶþ¸ºÔðÈË£»£¨3£©¡¶2ÐÍÌÇÄò²¡´óѪ¹Ü²¡±ä¶àÖØΣÏÕÒòËصĸÉÔ¤Ñо¿¡·£¬ÁÉÄþÊ¡½ÌÓýÌüÁ¢Ïî¹¥¹Ø¼Æ»®¿ÎÌ⣬ÏîÄ¿±àºÅ**£¬2006Äê½áÌ⣬ÅÅÃûµÚ¶þ¡£
´ú±íÎÄÕÂ
£¨1£©ÈËÒȵºËØÔ­»ùÒòÔÚÌåÍâÅàÑøµÄNIH3T3ϸ°ûÖеĻùÒòתÒÆÓë±í´ïÑо¿ ÖлªÄÚ·ÖÃÚ´úлÔÓÖ¾£¬2000Äê2ÔµÚ16¾íµÚ1ÆÚ£º34-37.ÂÛÖøÀ࣬µÚÒ»×÷Õߣ»£¨2£©Na/K ATPø»îÐÔ¼°ÆäATP1A1»ùÒò¶à̬ÐÔÓë2ÐÍÌÇÄò²¡ÖÜΧÉñ¾­²¡±äµÄÏà¹ØÐÔ ÖйúÌÇÄò²¡ÔÓÖ¾£¬2007ÄêµÚ15¾íµÚ4ÆÚ£º222-224.ÂÛÖøÀ࣬ͨѶ×÷Õߣ»£¨3£©VDR»ùÒòFork¢ñ¶à̬ÐÔÓëT2DM¼°ÆäºÏ²¢¶¯ÂöÓ²»¯µÄÏà¹ØÐÔÑо¿ ÖйúÌÇÄò²¡ÔÓÖ¾£¬2009Äê12ÔµÚ17¾íµÚ12ÆÚ£º892-894.ÂÛÖøÀ࣬µÚÒ»×÷Õß £»£¨4£©ºã¶¨ºÍ²¨¶¯¸ßÌǶԴóÊóÉöϵĤϸ°ûËðÉ˼°RAGE±í´ïµÄÓ°Ïì ÖлªÄÚ·ÖÃÚ´úлÔÓÖ¾£¬2010Äê12ÔµÚ26¾íµÚ12ÆÚ£º1063-1066.ÂÛÖøÀ࣬µÚÒ»×÷Õߣ»£¨5£©Ñª½¬Í¬ÐÍ°ëë×°±ËáˮƽÓë2ÐÍÌÇÄò²¡Î¸³¦Éñ¾­²¡±äµÄ¹Øϵ ÖйúÌÇÄò²¡ÔÓÖ¾£¬2011Äê4ÔµÚ19¾íµÚ4ÆÚ£º274-277.ÂÛÖøÀ࣬µÚÒ»×÷Õß £»£¨6£©Efficacy of switching from premixed insulin to insulin glargine regimen in Type 2 diabetes mellitus patients with different islet functions MOLECULAR MEDICINE REPORTS£¬Received August 13, 2013 Accepted April 2, 2014DOI: 10.3892/mmr.2014.2263(IF:1.17)£¨7£©ÊµÊ±¶¯Ì¬ÒȵºËرÃÓë¡°Ë«C¡±·½°¸¶ÔѪÌÇ¿ØÖƲ»¼ÑµÄ2ÐÍÌÇÄò²¡»¼ÕßµÄÁÆЧ¶Ô±È ÖлªÒ½Ñ§ÔÓÖ¾£¬2015Äê6ÔµÚ95¾íµÚ24ÆÚ£º1930-1933£¬ÂÛÖøÀ࣬ͨѶ×÷Õß £»£¨8£©Associations among glycemic excursions, glycated hemoglobin and high-sensitivity C-reactive protein in patients with poorly controlled type 2 diabetes mellitus EXPERIMENTAL AND THERAPEUTIC MEDICINE£¬2015£ºNov£»10£¨5£©£º1937-1942(IF:1.269)£¨9£©Anti-oxidative strss role of valsartan and fluvastatin in rat mesangial cells cultured with high glucoseInt J Clin Exp Med £¬2016:9(2):4016-4022(IF:1.277)£¨10£©Î÷¸ñÁÐÍ¡ºÍ·ü¸ñÁв¨ÌÇ·Ö±ðÁªºÏʵʩ¶¯Ì¬ÒȵºËرöÔÐÂÕï¶Ï2ÐÍÌÇÄò²¡»¼ÕßµÄÁÆЧ¶Ô±È ÖлªÒ½Ñ§ÔÓÖ¾£¬2016Äê8ÔµÚ96¾íµÚ32ÆÚ£º2552-2555£¬ÂÛÖøÀ࣬ͨѶ×÷Õß